Galectin Therapeutics reported $3.7M in Trade Creditors for its fiscal quarter ending in June of 2024.





Trade Creditors Change Date
AbbVie USD 3.59B 28.65B Dec/2025
Bristol-Myers Squibb USD 4.16B 76M Jun/2026
Galectin Therapeutics USD 3.7M 99K Jun/2024
Gilead Sciences USD 645M 70M Mar/2026
Immunic USD 11.01M 873K Mar/2026
Incyte USD 1.39B 1.16B Jun/2026
Merck USD 3.86B 541M Mar/2026